Roth Capital Initiates Coverage of Nautilus Biotechnology with Buy
Published . Updated .
Fintel reports that on September 29, 2026, Roth Capital initiated coverage of Nautilus Biotechnology (NASDAQCM:NAUT) with a Buy recommendation.On the day of the coverage initiation, September 29, 2026, the latest close for the stock was $1.36. This follows a pre-action close of $
Directly affected
- NAUT Nautilus Biotechnology
Named in this report.
Indirectly affected
- BDGS BRIDGES CAPITAL TACTICAL ETF
GA selected BDGS as a RELATED security because its canonical security name directly matches this event's themes: capital. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- BNDS SERIES PORTFOLIOS TRUST INFRASTRUCTURE CAPITAL BOND INCOME ETF
GA selected BNDS as a RELATED security because its canonical security name directly matches this event's themes: capital. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- CCFE CONCOURSE CAPITAL FOCUSED EQUITY ETF
GA selected CCFE as a RELATED security because its canonical security name directly matches this event's themes: capital. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- CGCB CAPITAL GRP FIXED INCM ETF T
GA selected CGCB as a RELATED security because its canonical security name directly matches this event's themes: capital. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- CGCP CAPITAL GRP FIXED INCM ETF T
GA selected CGCP as a RELATED security because its canonical security name directly matches this event's themes: capital. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- CGDV Capital Group Dividend Value - ETF
GA selected CGDV as a RELATED security because its canonical security name directly matches this event's themes: capital. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
Fintel reports that on September 29, 2026, Roth Capital initiated coverage of Nautilus Biotechnology (NASDAQCM:NAUT) with a Buy recommendation.On the day of the coverage initiation, September 29, 2026, the latest close for the stock was $1…
Source: Nasdaq Markets
Price since this story was published: Nautilus Biotechnology (NAUT)
Since the first closing price after “Roth Capital Initiates Coverage of Nautilus Biotechnology with Buy,” Nautilus Biotechnology (NAUT) is +69.87%. The S&P 500 fund (SPY) is +0.33% over the same days, a +69.54% difference versus the market.
Who gains and who loses around Nautilus Biotechnology (NAUT)
Companies tied to this story
- NAUT Nautilus Biotechnology
For “Roth Capital Initiates Coverage of Nautilus Biotechnology with Buy,” Nautilus Biotechnology (NAUT) is linked, with no stored direction, high confidence. Reason on file: The reported development directly names NAUTILUS BIOTECHNOLOGY INC in the headline; GA resolved that company to NAUT
- BDGS Bridges Capital Tactical Etf
For “Roth Capital Initiates Coverage of Nautilus Biotechnology with Buy,” Bridges Capital Tactical Etf (BDGS) is linked, with no stored direction, medium confidence. Reason on file: GA selected BDGS as a RELATED security because its canonical security name directly matches this event's themes: capital. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- BNDS Series Portfolios Trust Infrastructure Capital Bond Income Etf
For “Roth Capital Initiates Coverage of Nautilus Biotechnology with Buy,” Series Portfolios Trust Infrastructure Capital Bond Income Etf (BNDS) is linked, with no stored direction, medium confidence. Reason on file: GA selected BNDS as a RELATED security because its canonical security name directly matches this event's themes: capital. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- CCFE Concourse Capital Focused Equity Etf
Concourse Capital Focused Equity Etf (CCFE) is linked, with no stored direction, medium confidence in the 30 Sep 2026 story “Roth Capital Initiates Coverage of Nautilus Biotechnology with Buy.” Reason on file: GA selected CCFE as a RELATED security because its canonical security name directly matches this event's themes: capital. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- CGCB Capital Grp Fixed Incm Etf T
Capital Grp Fixed Incm Etf T (CGCB) is linked, with no stored direction, medium confidence in the 30 Sep 2026 story “Roth Capital Initiates Coverage of Nautilus Biotechnology with Buy.” Reason on file: GA selected CGCB as a RELATED security because its canonical security name directly matches this event's themes: capital. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- CGCP Capital Grp Fixed Incm Etf T
Capital Grp Fixed Incm Etf T (CGCP) is linked, with no stored direction, medium confidence in the 30 Sep 2026 story “Roth Capital Initiates Coverage of Nautilus Biotechnology with Buy.” Reason on file: GA selected CGCP as a RELATED security because its canonical security name directly matches this event's themes: capital. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- CGDV Capital Group Dividend Value - ETF
Capital Group Dividend Value - ETF (CGDV) is linked, with no stored direction, medium confidence in the 30 Sep 2026 story “Roth Capital Initiates Coverage of Nautilus Biotechnology with Buy.” Reason on file: GA selected CGDV as a RELATED security because its canonical security name directly matches this event's themes: capital. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Nautilus Biotechnology (NAUT)
On 30 Sep 2026, “Roth Capital Initiates Coverage of Nautilus Biotechnology with Buy” is the story that connects Nautilus Biotechnology (NAUT) to this story.
Nautilus Biotechnology (NAUT) is on the page because The reported development directly names NAUTILUS BIOTECHNOLOGY INC in the headline; GA resolved that company to NAUT
Bridges Capital Tactical Etf (BDGS) is here too. Its reason reads: GA selected BDGS as a RELATED security because its canonical security name directly matches this event's themes: capital. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Dates in the story, and the Nautilus Biotechnology (NAUT) price range
BDGS traded between 36.95 and 38.35 across 16 sessions. The latest close on file is 37.55. BNDS traded between 47.07 and 50.18 across 20 sessions. The latest close on file is 47.08. NAUT traded between 1.08 and 2.67 across 15 sessions. The latest close on file is 2.65.
What the saved facts support for Nautilus Biotechnology (NAUT)
46 out of 100
“Roth Capital Initiates Coverage of Nautilus Biotechnology with Buy” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.